Page last updated: 2024-08-25

ketorolac tromethamine and interleukin-8

ketorolac tromethamine has been researched along with interleukin-8 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cherney, E; Kim, SJ; Schoenberger, SD; Shah, R; Sheng, J	1

Trials

1 trial(s) available for ketorolac tromethamine and interleukin-8

Article	Year
Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy. JAMA ophthalmology, 2014, Volume: 132, Issue:1 Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Diabetic Retinopathy; Dinoprostone; Double-Blind Method; Female; Humans; Immunoenzyme Techniques; Interleukin-8; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Platelet-Derived Growth Factor; Prospective Studies; Vitrectomy; Vitreous Body	2014

Article

Year

Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.

JAMA ophthalmology, 2014, Volume: 132, Issue:1

Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Diabetic Retinopathy; Dinoprostone; Double-Blind Method; Female; Humans; Immunoenzyme Techniques; Interleukin-8; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Platelet-Derived Growth Factor; Prospective Studies; Vitrectomy; Vitreous Body

2014